All articles
- Mar. 21, 2024Company Info
EPNextS Group will collaborate with Frontage Laboratories, Inc. for Early Phase Clinical Trial and Clinical Site Management in the United States to Improve “Drug Lag” and “Drug Loss” Issues in Japan.
- Mar. 01, 2024Company Info
Notice of company name change to EP-Link Co., Ltd.
- Jul. 04, 2022Company Info
Announcement Concerning Acquisition of Shares of Total Trial Management Consulting Co., Ltd. Making it a Subsidiary
- Nov. 30, 2021Company Info
EP-SOGO and BitBrain announce demonstration examination and commencing operation of next-generation remote SDV system SPG-Remote Medical for SYNOV-R 2.0
- Oct. 04, 2021Company Info
EPS is celebrating its 30th Anniversary
- Aug. 03, 2021Company Info
EPS Holdings, Inc., our parent company has changed its parent company and its largest major shareholder
- Jul. 12, 2021Company Info
EP-SOGO Co., Ltd. received 3 stars, the highest rating of "Eruboshi Certification", which is issued to outstanding companies for the promotion of women's participation in the workplace.
- Jul. 12, 2021Company Info
Notice of E-mail Address Change
- Jun. 16, 2021Company Info
Next-Generation Remote Source Document Verification (R-SDV) System to Streamline and Accelerate Clinical Trial Operations
- Aug. 20, 2020Company Info
EP-SOGO Adopts Fujitsu’s tsClinical DDWorks 21/Trial Sites, a clinical study solution for investigational medical sites